APA (7th ed.) Citation

Furukawa, J., Kakei, Y., Murakami, S., Kita, H., Ueki, H., Hara, T., . . . Shirakawa, T. Safety and efficacy of oral cancer vaccine B440 in patients with PD-1/PD-L1 inhibitor-resistant advanced urothelial cancer: A study protocol for a phase 1 multicenter, open-label, single-arm clinical trial. BMC.

Chicago Style (17th ed.) Citation

Furukawa, Junya, et al. Safety and Efficacy of Oral Cancer Vaccine B440 in Patients with PD-1/PD-L1 Inhibitor-resistant Advanced Urothelial Cancer: A Study Protocol for a Phase 1 Multicenter, Open-label, Single-arm Clinical Trial. BMC.

MLA (9th ed.) Citation

Furukawa, Junya, et al. Safety and Efficacy of Oral Cancer Vaccine B440 in Patients with PD-1/PD-L1 Inhibitor-resistant Advanced Urothelial Cancer: A Study Protocol for a Phase 1 Multicenter, Open-label, Single-arm Clinical Trial. BMC.